Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Gallic Acid Induces Apoptosis in Oral Squamous Cell Carcinoma via PI3K/AKT/mTOR Pathway Inhibition and PTEN
Sanaz Helli1, Armin Heidari1, Armin Tafvizi1
1Department of Oral Medicine, TaMS.C., Islamic Azad University, Tabriz, Iran (the Islamic Republic of).
Abstract:
Oral squamous cell carcinoma is one of the most common head and neck cancers, which is associated with drug resistance and high mortality rates. The PI3K/AKT/mTOR pathway plays a crucial role in the survival, growth, and metastasis of cancer cells, making it a suitable target for targeted therapy.This study investigated the antitumor effects of gallic acid on CAL-27 cells, with a focus on the aforementioned pathway.CAL-27 cells were treated with different concentrations of gallic acid for 48 hours, and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed to assess viability. The expression of key genes and proteins in the PI3K/AKT/mTOR pathway, as well as apoptosis-related genes, was evaluated using the quantitative real-time reverse transcription polymerase chain reaction and western blot. Also, the activity of caspase-3/7 enzymes and the level of apoptosis were measured by fluorometric methods and enzyme-linked immunosorbent assay.Gallic acid significantly decreased oral squamous cell carcinoma cell viability in a dose- and time-dependent manner. The expression of PI3K, AKT, and mTOR genes and proteins was decreased, while PTEN expression was increased. Also, the increase in Bax expression and caspase activity indicated a strong induction of apoptosis by gallic acid.Gallic acid exhibits significant anticancer effects in oral squamous cell carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway and activating apoptotic pathways. This natural compound may contribute to the development of targeted therapies for oral cancer, pending further preclinical validation.
Insights
Gallic acid effectively reduced oral cancer cell viability by inhibiting the PI3K/AKT/mTOR pathway. This natural compound also activated apoptosis, showing promise for oral cancer targeted therapy.
Area of Science:
- Oncology
- Molecular Biology
- Natural Product Chemistry
Background:
- Oral squamous cell carcinoma (OSCC) presents significant challenges due to drug resistance and high mortality.
- The Phosphatidylinositol 3-kinase/Protein kinase B/Mammalian target of rapamycin (PI3K/AKT/mTOR) pathway is critical for cancer cell survival, growth, and metastasis.
- Targeting the PI3K/AKT/mTOR pathway offers a promising strategy for OSCC treatment.
Purpose of the Study:
- To investigate the antitumor effects of gallic acid on OSCC CAL-27 cells.
- To elucidate the impact of gallic acid on the PI3K/AKT/mTOR signaling pathway.
- To assess the induction of apoptosis by gallic acid in OSCC cells.
Main Methods:
- CAL-27 cells were treated with varying concentrations of gallic acid.
- Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
- Gene and protein expression (PI3K/AKT/mTOR pathway, apoptosis markers) were analyzed via quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and Western blot.
- Caspase-3/7 activity and apoptosis levels were quantified using fluorometric and enzyme-linked immunosorbent assay (ELISA) methods.
Main Results:
- Gallic acid demonstrated a dose- and time-dependent reduction in OSCC cell viability.
- Gallic acid treatment led to decreased expression of PI3K, AKT, and mTOR, and increased PTEN expression.
- Upregulation of Bax expression and enhanced caspase activity confirmed gallic acid-induced apoptosis.
Conclusions:
- Gallic acid exhibits potent anticancer properties against OSCC cells.
- Inhibition of the PI3K/AKT/mTOR pathway and activation of apoptotic pathways are key mechanisms of gallic acid's action.
- Gallic acid holds potential as a therapeutic agent for oral cancer, warranting further preclinical investigation.
More Related Videos
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway